The use of transcutaneous electrical nerve stimulation (TENS) for pain with IUD insertion: A randomized control trial
Contraception
Awarded 2024
Emerging Scholars in Family Planning
Meghana Kudrimoti, MD
Yale New Haven Hospital
$7,403

I am a resident physician in Obstetrics & Gynecology at Yale-New Haven Hospital in New Haven, Connecticut. As a medical student at The Ohio State College of Medicine, I volunteered as abortion doula at our local Planned Parenthood. Here, I witnessed the negative impact of the Dobbs decision firsthand. Originally from Lexington, Kentucky, my goal is to be a Complex Family Planning specialist at an academic medical center in the Midwest or South to provide contraceptive and abortion care. I aim to provide patient-centered, compassionate care to patients who have been marginalized by socioeconomic inequities, systemic racism, and restrictive laws making it difficult to receive essential reproductive healthcare. My project titled, “The Use of Transcutaneous Electrical Nerve Stimulation (TENS) for Pain with IUD Insertion: A Randomized Control Trial” is a double-blind, randomized, placebo-controlled trial that evaluates a novel way to mitigate pain during IUD insertion. TENS is a non-pharmacologic, cost-effective device that uses nerve stimulation to decrease hyperalgesia. In recent literature, TENS has been shown to decrease pain associated with dysmenorrhea, revealing its potential to decrease pain with IUD insertion. This study will randomize participants to the active TENS unit versus a TENS unit without power (placebo). Our primary outcome is pain at the time of IUD insertion using a 100-point visual analog scale (VAS). We will use surveys to determine the acceptability and participant experience of pain using the TENS device. Our goal is to improve the patient experience during IUD insertion by offering effective options for pain management.